Accuracy of the composite variability index as a measure of the balance between nociception and antinociception during anesthesia

Anesth Analg. 2014 Aug;119(2):288-301. doi: 10.1213/ANE.0000000000000274.

Abstract

Background: The Composite Variability Index (CVI), derived from the electroencephalogram, was developed to assess the antinociception-nociception balance, whereas the Bispectral Index (BIS) was developed to assess the hypnotic state during anesthesia. We studied the relationships between these indices, level of hypnosis (BIS level), and antinociception (predicted remifentanil effect-site concentrations, CeREMI) before and after stimulation. Also, we measured their association with movement in response to a noxious stimulus.

Methods: We randomized 120 patients to one of 12 groups targeting different hypnotic levels (BIS 70, 50, and 30) and various CeREMI (0, 2, 4, or 6 ng/mL). At pseudo-steady state, baseline values were observed, and a series of stimuli were applied. Changes in BIS, CVI, heart rate (HR), and mean arterial blood pressure (MAP) between baseline and response period were analyzed in relation to level of hypnosis, antinociception, and somatic response to the stimuli.

Results: CVI and BIS more accurately correlate with somatic response to an Observer Assessment of Alertness and Sedation-noxious stimulation than HR, MAP, CeREMI, and propofol effect-site concentration (Tukey post hoc tests P < 0.01). Change in CVI is more adequate to monitor response to stimulation than changes in BIS, HR, or MAP (as described by the Mathews Correlation Coefficient with significance level set at P < 0.001). In contrast, none of the candidate analgesic state indices was uniquely related to a specific opioid concentration and is extensively influenced by the hypnotic state as measured by BIS.

Conclusions: CVI appears to correlate with somatic responses to noxious stimuli. However, unstimulated CVI depends more on hypnotic drug effect than on opioid concentration.

Trial registration: ClinicalTrials.gov NCT01053611.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Opioid / administration & dosage*
  • Anesthetics, Intravenous / administration & dosage
  • Arterial Pressure / drug effects
  • Attention / drug effects
  • Consciousness / drug effects*
  • Consciousness Monitors
  • Electroencephalography* / instrumentation
  • Heart Rate / drug effects
  • Humans
  • Hypnotics and Sedatives / administration & dosage*
  • Monitoring, Intraoperative / instrumentation
  • Monitoring, Intraoperative / methods*
  • Netherlands
  • Nociception / drug effects*
  • Pain Threshold / drug effects
  • Piperidines / administration & dosage*
  • Predictive Value of Tests
  • Propofol / administration & dosage
  • Remifentanil
  • Reproducibility of Results
  • Time Factors

Substances

  • Analgesics, Opioid
  • Anesthetics, Intravenous
  • Hypnotics and Sedatives
  • Piperidines
  • Remifentanil
  • Propofol

Associated data

  • ClinicalTrials.gov/NCT01053611